SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS

The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing...

Full description

Saved in:
Bibliographic Details
Main Author HAMANAKA ERNEST SEIICHI
Format Patent
LanguageEnglish
Published 15.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. The compounds are also useful for the treatment of negative energy balance (NEB) and associated diseases in ruminants. ® KIPO & WIPO 2007
AbstractList The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use of such compounds as peroxisome proliferator activator receptor (PPAR) agonists. PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans. The compounds are also useful for the treatment of negative energy balance (NEB) and associated diseases in ruminants. ® KIPO & WIPO 2007
Author HAMANAKA ERNEST SEIICHI
Author_xml – fullname: HAMANAKA ERNEST SEIICHI
BookMark eNrjYmDJy89L5WQwDQ51Cg7xDAkNcXVR8HANcQ3ydwyK9NFVcPRzUQjwcPWL9AkO9XFz9PWP9FFw9vcN8A_1cwnmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBgbmBgbGBkYW5o7GxKkCANfrKtM
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20070030287A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20070030287A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:55:11 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20070030287A3
Notes Application Number: KR20077001570
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070315&DB=EPODOC&CC=KR&NR=20070030287A
ParticipantIDs epo_espacenet_KR20070030287A
PublicationCentury 2000
PublicationDate 20070315
PublicationDateYYYYMMDD 2007-03-15
PublicationDate_xml – month: 03
  year: 2007
  text: 20070315
  day: 15
PublicationDecade 2000
PublicationYear 2007
RelatedCompanies PFIZER PRODUCTS INC
RelatedCompanies_xml – name: PFIZER PRODUCTS INC
Score 2.6651886
Snippet The present invention is directed at substituted heteroaryl- and phenylsulfamoyl compounds, pharmaceutical compositions containing such compounds and the use...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070315&DB=EPODOC&locale=&CC=KR&NR=20070030287A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcKhV1JtWxUeVgJLbomuSpj0EyZNo8yIPaU4lSTcgSFpsxN93krbaU2_LDsw-mPfszAI8SLSkz5lckqyUZCIyxsioFBlh2fBpmFEkkVlT7-x6AzsR3ybSpAOfm1qYtk_oT9scETmqQH6vW3m9-A9iGe3byuVj_oFT8xcrVgx-4x033dgl3tAUM_ANX-d1XRmHvBeuYEjQ6CCoe7CPhrTcPAAz37WmLmWxrVSsEzgIEF9Vn0KHVT040jd_r_Xg0F2nvHG45r7lGUhRokXxa5ygtOFsEw1RXw1Th3CqZ3CBbXqpEyWOpbp-6nC67wZ-4hnROdxbZqzbBNef_h13Og63NytcQLeaV-wSuCZHLBRUpIwKYlHkuTwYNWlIVma5IGSDK-jvwnS9G3wDx6u4pUCo1Idu_fXNblHh1vlde0-_Tkt_BA
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcKhVrDetio-qASW3RdckbXookuZBavMiD2lOIYkbECQtNuLvO0lb7am3ZQdmH8x7dmYBHiRa0Od0UJC0kAZEZIyRYSEywlL5SU4pksh7Xe9sO30zEl9n0qwFn5tamKZP6E_THBE5Kkd-rxp5vfgPYmnN28rlY_aBU_MXIxxp_MY7rruxS7w2Humeq7kqr6qjqc87_gqGBI0OgrIH-2hky3Wnff1tXNelLLaVinEMBx7iK6sTaLGyCx118_daFw7tdcobh2vuW56CFETjIJyEEUobztTREHUVP7YIpzga55m6E1tBZBmK7cYWp7q250aOFpzBvaGHqklw_eTvuMnU396scA7tcl6yC-DqHLGQU5EyKoh5nmWD_rBOQ7IizQQh7V9Cbxemq93gO-iYoW0l1sSZXsPRKoYpECr1oF19fbMbVL5Vdtvc2S9rA4H0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+HETEROARYL-+AND+PHENYLSULFAMOYL+COMPOUNDS&rft.inventor=HAMANAKA+ERNEST+SEIICHI&rft.date=2007-03-15&rft.externalDBID=A&rft.externalDocID=KR20070030287A